Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Globus Medical (NYSE: GMED), a leading musculoskeletal technology company, has announced its participation in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. The company's management team is scheduled to deliver a presentation on Monday, March 10, 2025, at 4:30 PM Pacific Time.
Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website under the 'News & Events' and 'Events & Webcasts' sections at investors.globusmedical.com.
Globus Medical (NYSE: GMED), un'azienda leader nel settore della tecnologia muscoloscheletrica, ha annunciato la sua partecipazione alla Conferenza Muscoloscheletrica Canaccord Genuity 2025 a San Diego. Il team di gestione dell'azienda è programmato per tenere una presentazione lunedì 10 marzo 2025, alle 16:30 ora del Pacifico.
Gli investitori e le parti interessate possono accedere sia alla presentazione dal vivo che alla registrazione del webcast attraverso il sito web delle relazioni con gli investitori dell'azienda, nelle sezioni 'Notizie & Eventi' e 'Eventi & Webcast' su investors.globusmedical.com.
Globus Medical (NYSE: GMED), una empresa líder en tecnología musculoesquelética, ha anunciado su participación en la Conferencia Musculoesquelética Canaccord Genuity 2025 en San Diego. El equipo de gestión de la empresa está programado para realizar una presentación el lunes 10 de marzo de 2025, a las 16:30 hora del Pacífico.
Los inversores y partes interesadas pueden acceder tanto a la presentación en vivo como al webcast archivado a través del sitio web de relaciones con inversores de la empresa en las secciones 'Noticias y Eventos' y 'Eventos y Webcasts' en investors.globusmedical.com.
글로부스 메디컬 (NYSE: GMED), 근골격계 기술 분야의 선두 기업,가 샌디에고에서 열리는 캐너코드 제뉴이티 2025 근골격계 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2025년 3월 10일 월요일, 태평양 표준시 기준 오후 4시 30분에 발표를 진행할 예정입니다.
투자자 및 관심 있는 당사자는 회사의 투자자 관계 웹사이트에서 '뉴스 및 이벤트'와 '이벤트 및 웹캐스트' 섹션을 통해 실시간 발표 및 아카이브된 웹캐스트에 접근할 수 있습니다. investors.globusmedical.com.
Globus Medical (NYSE: GMED), une entreprise leader dans le domaine de la technologie musculo-squelettique, a annoncé sa participation à la Conférence Musculo-Squelettique Canaccord Genuity 2025 à San Diego. L'équipe de direction de l'entreprise doit présenter le lundi 10 mars 2025, à 16h30, heure du Pacifique.
Les investisseurs et les parties intéressées peuvent accéder à la fois à la présentation en direct et à l'archivage du webinaire via le site web des relations investisseurs de l'entreprise, dans les sections 'Actualités & Événements' et 'Événements & Webinaires' à l'adresse investors.globusmedical.com.
Globus Medical (NYSE: GMED), ein führendes Unternehmen im Bereich der muskuloskelettalen Technologie, hat seine Teilnahme an der Canaccord Genuity 2025 Muskuloskelettalen Konferenz in San Diego bekannt gegeben. Das Management-Team des Unternehmens wird am Montag, den 10. März 2025, um 16:30 Uhr pazifischer Zeit eine Präsentation halten.
Investoren und interessierte Parteien können sowohl auf die Live-Präsentation als auch auf das archivierte Webcast über die Investor-Relations-Website des Unternehmens in den Bereichen 'Nachrichten & Veranstaltungen' und 'Veranstaltungen & Webcasts' unter investors.globusmedical.com zugreifen.
- None.
- None.
Monday, March 10, 2025 at 4:30 pm Pacific Time
AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.
Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at https://www.investors.globusmedical.com/news-events/events-webcasts.
About Globus Medical, Inc.
Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
When is Globus Medical (GMED) presenting at the Canaccord Genuity 2025 Conference?
How can investors watch GMED's Canaccord Genuity Conference presentation?
Where is the Canaccord Genuity 2025 Musculoskeletal Conference being held?
What type of technology company is GMED?
